Papadopoulou-Marketou N, Paschou SA, Marketos N, Adamidi S, Adamidis S, Kanaka-Gantenbein C.
Minerva Med. 2018 Jun;109(3):218-228. doi: 10.23736/S0026-4806.17.05496-9. Epub 2017 Dec 4.
PMID:29205998
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes.
Khurana I, Kaipananickal H, Maxwell S, Birkelund S, Syreeni A, Forsblom C, Okabe J, Ziemann M, Kaspi A, Rafehi H, Jørgensen A, Al-Hasani K, Thomas MC, Jiang G, Luk AO, Lee HM, Huang Y, Thewjitcharoen Y, Nakasatien S, Himathongkam T, Fogarty C, Njeim R, Eid A, Hansen TW, Tofte N, Ottesen EC, Ma RC, Chan JC, Cooper ME, Rossing P, Groop PH, El-Osta A.
J Clin Invest. 2023 Feb 15;133(4):e160959. doi: 10.1172/JCI160959.
Diabetes Care. 2021 Jan;44(1):174-180. doi: 10.2337/dc20-0493. Epub 2020 Nov 11.
PMID:33177173
Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study.
Piccoli GB, Clari R, Ghiotto S, Castelluccia N, Colombi N, Mauro G, Tavassoli E, Melluzza C, Cabiddu G, Gernone G, Mongilardi E, Ferraresi M, Rolfo A, Todros T.